Armando Espinoza Santana

Dr. Armando Espinoza Santana


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
JCJordana Mariane Neyra Chauca
Jordana Mariane Neyra Chauca
MVMaclovia Vázquez VanDyck
Maclovia Vázquez VanDyck
ASArmando Espinoza Santana
Armando Espinoza Santana
GMGraciela Robles Martinez
Graciela Robles Martinez
KVKalid Alejandra Romero Vega
Kalid Alejandra Romero Vega
VFVANESSA FAVILA
VANESSA FAVILA
Background: Aging exerts a progressive and multifaceted impact on the microcirculatory system, undermining the structural and molecular integrity that sustains endothelial stability across both peripheral and cerebral vascular territories. A sustained shift toward oxidative imbalance, chronic low-grade inflammation, and progressive endothelial exhaustion converges to destabilize microvascular networks, linking peripheral artery disease (PAD) with heightened susceptibility to cerebral microvascular dysfunction and neurovascular decline. As redox homeostasis deteriorates, endothelial cells progressively lose barrier-selective properties, intercellular communication with pericytes weakens, and pro-thrombotic tendencies subtly emerge, creating a permissive environment for early neurovascular injury and impaired cerebrovascular resilience. Methods: This narrative review integrates mechanistic evidence derived from experimental, clinical, and translational studies examining the interplay between oxidative stress, inflammatory signaling cascades, endothelial senescence, and blood–brain barrier (BBB) disruption across peripheral and cerebral microvascular systems. A comparative framework was applied to PAD and cerebral microcirculatory pathology to identify convergent molecular drivers and systemic mechanisms underlying endothelial deterioration. Results: Accumulating evidence demonstrates that oxidative stress disrupts endothelial mitochondrial function, compromises tight junction architecture, and accelerates angiogenic failure. Concurrent inflammatory activation amplifies these alterations through cytokine-mediated endothelial activation, enhanced leukocyte adhesion, and promotion of a pro-thrombotic microenvironment. Progressive endothelial senescence consolidates these insults into a persistent state of microvascular dysfunction characterized by diminished nitric oxide bioavailability, capillary rarefaction, and compromised barrier integrity. Notably, these pathological features are shared between PAD and the aging cerebral circulation, reinforcing the concept of a unified systemic microvascular aging phenotype. Conclusions: Microvascular failure in the aging brain should be understood as an extension of systemic endothelial deterioration driven by oxidative stress, chronic inflammation, and senescence-associated vascular exhaustion. Recognizing the shared molecular architecture linking peripheral and cerebral microcirculatory dysfunction offers a strategic framework for developing targeted therapeutic interventions aimed at restoring endothelial resilience, stabilizing BBB integrity, and preserving neurovascular homeostasis in aging populations.

10 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JCJordana Mariane Neyra Chauca
Jordana Mariane Neyra Chauca
MVMaclovia Vázquez VanDyck
Maclovia Vázquez VanDyck
ASArmando Espinoza Santana
Armando Espinoza Santana
GMGraciela Robles Martinez
Graciela Robles Martinez
KVKalid Alejandra Romero Vega
Kalid Alejandra Romero Vega
VFVANESSA FAVILA
VANESSA FAVILA
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis share common molecular mechanisms involving oxidative stress, neuroinflammation, and microvascular dysfunction. These interrelated processes form a self-perpetuating cycle that accelerates neuronal loss and cognitive decline. Oxidative stress triggers mitochondrial impairment and lipid peroxidation, while chronic glial activation amplifies the inflammatory milieu through cytokine release and reactive oxygen species generation. Concurrently, endothelial and pericytic injury disrupts the blood–brain barrier (BBB), compromising neurovascular coupling and metabolic homeostasis. This review summarizes the mechanistic crosstalk between oxidative, inflammatory, and vascular pathways in neurodegeneration, highlighting recent advances in antioxidant, anti-inflammatory, and vasoprotective strategies. We further discuss emerging therapeutic approaches such as nanocarrier-based delivery systems, multitarget drugs, and genetic modulation aimed at restoring redox balance and microvascular integrity. Understanding the molecular intersections of these mechanisms may provide new insights into disease-modifying interventions for neurodegenerative disorders.